Assyro AI

FDA Orange Book · active-ingredient family

Propantheline bromide

Propantheline bromide is approved as 2 brand and 11 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:PRO-BANTHINE · NDA 008732

2

Brand (NDA)

11

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable, tablet

ProductApplicantApplicationTEApproved
PRO-BANTHINERLD×2SHIRENDA 008732Approved Prior to Jan 1, 1982
PRO-BANTHINEGD SEARLE LLCNDA 008843Approved Prior to Jan 1, 1982

Generic (ANDA) products (11)

ProductApplicantApplicationTEApproved
PROPANTHELINE BROMIDEPAR PHARMANDA 088377Dec 08, 1983
PROPANTHELINE BROMIDEASCOTANDA 087663Oct 25, 1982
PROPANTHELINE BROMIDEHEATHERANDA 085780Approved Prior to Jan 1, 1982
PROPANTHELINE BROMIDE×2HIKMAANDA 080927Approved Prior to Jan 1, 1982
PROPANTHELINE BROMIDEIMPAX LABSANDA 084541Approved Prior to Jan 1, 1982
PROPANTHELINE BROMIDEMYLANANDA 083706Approved Prior to Jan 1, 1982
PROPANTHELINE BROMIDEPVT FORMANDA 080977Approved Prior to Jan 1, 1982
PROPANTHELINE BROMIDESANDOZANDA 080928Approved Prior to Jan 1, 1982
PROPANTHELINE BROMIDETABLICAPSANDA 084428Approved Prior to Jan 1, 1982
PROPANTHELINE BROMIDEWATSON LABSANDA 083029Approved Prior to Jan 1, 1982
PROPANTHELINE BROMIDEWATSON LABSANDA 083151Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Propantheline bromide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.